NCT01854060

Brief Summary

The prevalence of IBS in the community has been reported in numerous cross-sectional surveys. However, less is known about the incidence of IBS ,mainly due to its slow development and to patients under-reporting. Furthermore, only one study has analyzed data concerning potential risk factors for the diagnosis of IBS. The investigators will examine the incidence of IBS in a large cohort of young adults and will look at the association of socioeconomic, anthropometric and occupational factors with IBS incidence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
440,822

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

May 12, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 15, 2013

Completed
Last Updated

May 15, 2013

Status Verified

May 1, 2013

Enrollment Period

4 months

First QC Date

May 12, 2013

Last Update Submit

May 14, 2013

Conditions

Keywords

Irritable bowel syndromeEpidimiologyDeterioration in the severity of irritable bowel syndrome

Outcome Measures

Primary Outcomes (1)

  • Incidence of clinical diagnosis of irritable bowel syndrome

    New diagnosis of irritable bowel syndrome during this priod

    6 years

Secondary Outcomes (1)

  • predictive factors for the clinical diagnosis of irritable bowel syndrome

    6 years

Study Arms (1)

irritable bowel syndrome

All new cases of clinical diagnosis of irritable bowel syndrome

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of Israeli men and women aged 18-39 years who served in active military service (mandatory and career service) between the years 2005-2011

You may qualify if:

  • All Israeli men and women
  • aged 18-39 years
  • served in active military service (mandatory and career service) between the years 2005-2011

You may not qualify if:

  • Diagnosis of celiac disease
  • Inflammatory bowel disease
  • Cancer in the digestive system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Israel Defence Forces, Medical Corps

Ramat Gan, 53261, Israel

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Gastro Service

Study Record Dates

First Submitted

May 12, 2013

First Posted

May 15, 2013

Study Start

January 1, 2013

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

May 15, 2013

Record last verified: 2013-05

Locations